

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein activation cascade (GO:0072376) | 9.10232614 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 8.20923204 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 8.20923204 |
| 4 | signal peptide processing (GO:0006465) | 8.05511794 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 7.88983132 |
| 6 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 7.63329596 |
| 7 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 7.63329596 |
| 8 | Fc-gamma receptor signaling pathway (GO:0038094) | 7.63329596 |
| 9 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 7.52747704 |
| 10 | negative regulation of glucose import (GO:0046325) | 7.24896959 |
| 11 | positive regulation of Rho protein signal transduction (GO:0035025) | 7.12554254 |
| 12 | humoral immune response (GO:0006959) | 6.98437300 |
| 13 | retina homeostasis (GO:0001895) | 6.97202921 |
| 14 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 5.83699012 |
| 15 | negative regulation of B cell proliferation (GO:0030889) | 5.83375875 |
| 16 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 5.79738316 |
| 17 | negative regulation of glucose transport (GO:0010829) | 5.70590902 |
| 18 | fucose catabolic process (GO:0019317) | 5.69631769 |
| 19 | L-fucose metabolic process (GO:0042354) | 5.69631769 |
| 20 | L-fucose catabolic process (GO:0042355) | 5.69631769 |
| 21 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 5.36970904 |
| 22 | apoptotic cell clearance (GO:0043277) | 5.09850026 |
| 23 | presynaptic membrane organization (GO:0097090) | 4.87124819 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.80423174 |
| 25 | positive regulation of Rap GTPase activity (GO:0032854) | 4.70475210 |
| 26 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.63584558 |
| 27 | protein N-linked glycosylation via asparagine (GO:0018279) | 4.60217436 |
| 28 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.57545033 |
| 29 | peptidyl-asparagine modification (GO:0018196) | 4.54519522 |
| 30 | positive regulation of nuclease activity (GO:0032075) | 4.44805247 |
| 31 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 4.36470785 |
| 32 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.35409004 |
| 33 | positive regulation of B cell differentiation (GO:0045579) | 4.34338625 |
| 34 | protein N-linked glycosylation (GO:0006487) | 4.33387406 |
| 35 | COPII vesicle coating (GO:0048208) | 4.28048358 |
| 36 | regulation of B cell proliferation (GO:0030888) | 4.24312639 |
| 37 | regulation of nuclease activity (GO:0032069) | 4.18108497 |
| 38 | cellular response to unfolded protein (GO:0034620) | 4.16468237 |
| 39 | response to endoplasmic reticulum stress (GO:0034976) | 4.11244013 |
| 40 | mannose metabolic process (GO:0006013) | 4.09277247 |
| 41 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 4.07961881 |
| 42 | antibacterial humoral response (GO:0019731) | 4.07471554 |
| 43 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 4.07380564 |
| 44 | B cell receptor signaling pathway (GO:0050853) | 4.06122502 |
| 45 | regulation of Rap GTPase activity (GO:0032317) | 4.03321923 |
| 46 | exocrine pancreas development (GO:0031017) | 4.02496834 |
| 47 | N-acetylneuraminate metabolic process (GO:0006054) | 3.99127701 |
| 48 | cellular response to zinc ion (GO:0071294) | 3.93015632 |
| 49 | ER-nucleus signaling pathway (GO:0006984) | 3.89381793 |
| 50 | cellular response to topologically incorrect protein (GO:0035967) | 3.87515557 |
| 51 | antimicrobial humoral response (GO:0019730) | 3.84967378 |
| 52 | COPI coating of Golgi vesicle (GO:0048205) | 3.82118171 |
| 53 | Golgi transport vesicle coating (GO:0048200) | 3.82118171 |
| 54 | proline biosynthetic process (GO:0006561) | 3.66817703 |
| 55 | regulation of B cell differentiation (GO:0045577) | 3.58875066 |
| 56 | bone resorption (GO:0045453) | 3.56139040 |
| 57 | maternal placenta development (GO:0001893) | 3.51732311 |
| 58 | positive regulation of immunoglobulin production (GO:0002639) | 3.50403592 |
| 59 | cellular response to antibiotic (GO:0071236) | 3.49647306 |
| 60 | presynaptic membrane assembly (GO:0097105) | 3.49481340 |
| 61 | C21-steroid hormone biosynthetic process (GO:0006700) | 3.45176366 |
| 62 | respiratory burst (GO:0045730) | 3.40998749 |
| 63 | intestinal epithelial cell development (GO:0060576) | 3.40937882 |
| 64 | nerve growth factor signaling pathway (GO:0038180) | 3.33454845 |
| 65 | negative regulation of osteoclast differentiation (GO:0045671) | 3.33050036 |
| 66 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 3.24659863 |
| 67 | defense response to Gram-negative bacterium (GO:0050829) | 3.23145472 |
| 68 | histone H3-K36 demethylation (GO:0070544) | 3.22869400 |
| 69 | response to unfolded protein (GO:0006986) | 3.19670855 |
| 70 | B cell proliferation (GO:0042100) | 3.19075822 |
| 71 | Rap protein signal transduction (GO:0032486) | 3.08199668 |
| 72 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.06915929 |
| 73 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.05777604 |
| 74 | immune response-activating signal transduction (GO:0002757) | 3.02072781 |
| 75 | response to topologically incorrect protein (GO:0035966) | 3.00786946 |
| 76 | Fc receptor signaling pathway (GO:0038093) | 2.97594256 |
| 77 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.95582932 |
| 78 | Fc-epsilon receptor signaling pathway (GO:0038095) | 2.95028036 |
| 79 | mature B cell differentiation (GO:0002335) | 2.94595104 |
| 80 | negative regulation of cellular response to insulin stimulus (GO:1900077) | 2.92758165 |
| 81 | sialylation (GO:0097503) | 2.86983255 |
| 82 | establishment of endothelial barrier (GO:0061028) | 2.86962001 |
| 83 | negative regulation of B cell activation (GO:0050869) | 2.86225818 |
| 84 | immune response-regulating cell surface receptor signaling pathway (GO:0002768) | 2.83608566 |
| 85 | regulation of immunoglobulin production (GO:0002637) | 2.83433455 |
| 86 | fucose metabolic process (GO:0006004) | 2.82514633 |
| 87 | regulation of B cell activation (GO:0050864) | 2.81648891 |
| 88 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.80986775 |
| 89 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.79775757 |
| 90 | activation of immune response (GO:0002253) | 2.77798661 |
| 91 | sequestering of metal ion (GO:0051238) | 2.77456014 |
| 92 | fucosylation (GO:0036065) | 2.76938413 |
| 93 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.75643598 |
| 94 | cellular response to ATP (GO:0071318) | 2.74862743 |
| 95 | regulation of interleukin-5 production (GO:0032674) | 2.71291961 |
| 96 | glucocorticoid biosynthetic process (GO:0006704) | 2.70462287 |
| 97 | histone H3-K9 demethylation (GO:0033169) | 2.69463674 |
| 98 | negative regulation of interleukin-10 production (GO:0032693) | 2.67092941 |
| 99 | complement activation, classical pathway (GO:0006958) | 17.8459662 |
| 100 | complement activation (GO:0006956) | 13.7364647 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 7.86026481 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.77768357 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.55803173 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.20236905 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.88642025 |
| 6 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.68265874 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 3.66865138 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.13094174 |
| 9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.94635062 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.83939113 |
| 11 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.83822370 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.77888815 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.75600689 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.71499902 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.50745167 |
| 16 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.49439011 |
| 17 | MYB_26560356_Chip-Seq_TH2_Human | 2.42252891 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.34879269 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.33731111 |
| 20 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.21062894 |
| 21 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.11476846 |
| 22 | MYB_26560356_Chip-Seq_TH1_Human | 2.01824543 |
| 23 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.99003832 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.96193894 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.91146947 |
| 26 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.87933616 |
| 27 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.85626824 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.81789522 |
| 29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.80933019 |
| 30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.79470749 |
| 31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.78632840 |
| 32 | RXR_22108803_ChIP-Seq_LS180_Human | 1.77501641 |
| 33 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.73638201 |
| 34 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.64044995 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.63273367 |
| 36 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.61647203 |
| 37 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.58081120 |
| 38 | UTX_26944678_Chip-Seq_JUKART_Human | 1.49512517 |
| 39 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.48595157 |
| 40 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.47011159 |
| 41 | GATA3_26560356_Chip-Seq_TH2_Human | 1.45654332 |
| 42 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.43071288 |
| 43 | SPI1_23127762_ChIP-Seq_K562_Human | 1.41064126 |
| 44 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.38680256 |
| 45 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.33548479 |
| 46 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.32831579 |
| 47 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30229066 |
| 48 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28667018 |
| 49 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.22074302 |
| 50 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.21358770 |
| 51 | KDM2B_26808549_Chip-Seq_K562_Human | 1.19626051 |
| 52 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18602881 |
| 53 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.18315110 |
| 54 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.17037025 |
| 55 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.16528735 |
| 56 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.16248182 |
| 57 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15083212 |
| 58 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.14803262 |
| 59 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.13917560 |
| 60 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.13138534 |
| 61 | MAF_26560356_Chip-Seq_TH2_Human | 1.12042753 |
| 62 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08017127 |
| 63 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05843957 |
| 64 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.03909260 |
| 65 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.01525782 |
| 66 | GATA2_19941826_ChIP-Seq_K562_Human | 1.01123977 |
| 67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.01122777 |
| 68 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.99142683 |
| 69 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.98183754 |
| 70 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.94180334 |
| 71 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94065872 |
| 72 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92888601 |
| 73 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92867508 |
| 74 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.92484941 |
| 75 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92032258 |
| 76 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91746865 |
| 77 | GATA1_19941826_ChIP-Seq_K562_Human | 0.91093427 |
| 78 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.90487330 |
| 79 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.90253656 |
| 80 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.90175697 |
| 81 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.89352882 |
| 82 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.88040905 |
| 83 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.87880294 |
| 84 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.84875995 |
| 85 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.82654972 |
| 86 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.82389883 |
| 87 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.82389883 |
| 88 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.81084974 |
| 89 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.80156317 |
| 90 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.79665370 |
| 91 | GATA1_22025678_ChIP-Seq_K562_Human | 0.78269370 |
| 92 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.77802835 |
| 93 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.75106345 |
| 94 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.74750580 |
| 95 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.73977580 |
| 96 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.73884523 |
| 97 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.73298824 |
| 98 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72948415 |
| 99 | GATA3_26560356_Chip-Seq_TH1_Human | 0.71987561 |
| 100 | P300_27268052_Chip-Seq_Bcells_Human | 0.71825812 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 7.44251509 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.96566480 |
| 3 | MP0001800_abnormal_humoral_immune | 4.21975806 |
| 4 | MP0005387_immune_system_phenotype | 3.77368647 |
| 5 | MP0001790_abnormal_immune_system | 3.77368647 |
| 6 | MP0004264_abnormal_extraembryonic_tissu | 3.68745156 |
| 7 | MP0003300_gastrointestinal_ulcer | 3.49192512 |
| 8 | MP0001879_abnormal_lymphatic_vessel | 3.26063409 |
| 9 | MP0005671_abnormal_response_to | 3.15480753 |
| 10 | MP0002452_abnormal_antigen_presenting | 2.99254857 |
| 11 | MP0010234_abnormal_vibrissa_follicle | 2.63371127 |
| 12 | MP0002723_abnormal_immune_serum | 2.42451182 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.31138328 |
| 14 | MP0002420_abnormal_adaptive_immunity | 2.28805765 |
| 15 | MP0001819_abnormal_immune_cell | 2.23897493 |
| 16 | MP0000716_abnormal_immune_system | 2.13120384 |
| 17 | MP0002398_abnormal_bone_marrow | 2.04285759 |
| 18 | MP0005025_abnormal_response_to | 2.03241036 |
| 19 | MP0010155_abnormal_intestine_physiology | 1.97594151 |
| 20 | MP0003436_decreased_susceptibility_to | 1.94465314 |
| 21 | MP0003868_abnormal_feces_composition | 1.86996521 |
| 22 | MP0000689_abnormal_spleen_morphology | 1.84706307 |
| 23 | MP0001845_abnormal_inflammatory_respons | 1.76767088 |
| 24 | MP0003195_calcinosis | 1.68944061 |
| 25 | MP0002429_abnormal_blood_cell | 1.65594448 |
| 26 | MP0008569_lethality_at_weaning | 1.65353851 |
| 27 | MP0010352_gastrointestinal_tract_polyps | 1.64790725 |
| 28 | MP0002148_abnormal_hypersensitivity_rea | 1.61266510 |
| 29 | MP0002166_altered_tumor_susceptibility | 1.59162168 |
| 30 | MP0001873_stomach_inflammation | 1.58738407 |
| 31 | MP0000465_gastrointestinal_hemorrhage | 1.52443339 |
| 32 | MP0000685_abnormal_immune_system | 1.49273663 |
| 33 | MP0004134_abnormal_chest_morphology | 1.46145102 |
| 34 | MP0002722_abnormal_immune_system | 1.44812038 |
| 35 | MP0002419_abnormal_innate_immunity | 1.42151807 |
| 36 | MP0002396_abnormal_hematopoietic_system | 1.41411305 |
| 37 | MP0001663_abnormal_digestive_system | 1.38682703 |
| 38 | MP0009046_muscle_twitch | 1.30736710 |
| 39 | MP0000490_abnormal_crypts_of | 1.26545324 |
| 40 | MP0002006_tumorigenesis | 1.26035147 |
| 41 | MP0002933_joint_inflammation | 1.26019169 |
| 42 | MP0009333_abnormal_splenocyte_physiolog | 1.22605949 |
| 43 | MP0002254_reproductive_system_inflammat | 1.19779629 |
| 44 | MP0003866_abnormal_defecation | 1.17381125 |
| 45 | MP0004947_skin_inflammation | 1.17170913 |
| 46 | MP0001919_abnormal_reproductive_system | 1.15238767 |
| 47 | MP0001944_abnormal_pancreas_morphology | 1.12213799 |
| 48 | MP0009785_altered_susceptibility_to | 1.10459212 |
| 49 | MP0005360_urolithiasis | 1.07886619 |
| 50 | MP0003075_altered_response_to | 1.07668573 |
| 51 | MP0004510_myositis | 1.04152393 |
| 52 | MP0005310_abnormal_salivary_gland | 1.03821788 |
| 53 | MP0005085_abnormal_gallbladder_physiolo | 1.03821353 |
| 54 | MP0000920_abnormal_myelination | 1.03434545 |
| 55 | MP0002693_abnormal_pancreas_physiology | 1.02895623 |
| 56 | MP0003763_abnormal_thymus_physiology | 1.02261663 |
| 57 | MP0002136_abnormal_kidney_physiology | 1.01060797 |
| 58 | MP0002139_abnormal_hepatobiliary_system | 1.00647061 |
| 59 | MP0008872_abnormal_physiological_respon | 0.96097675 |
| 60 | MP0005381_digestive/alimentary_phenotyp | 0.94792000 |
| 61 | MP0002405_respiratory_system_inflammati | 0.92972671 |
| 62 | MP0001533_abnormal_skeleton_physiology | 0.92662046 |
| 63 | MP0001666_abnormal_nutrient_absorption | 0.92151453 |
| 64 | MP0002998_abnormal_bone_remodeling | 0.90941443 |
| 65 | MP0002168_other_aberrant_phenotype | 0.85567157 |
| 66 | MP0008995_early_reproductive_senescence | 0.84895546 |
| 67 | MP0000703_abnormal_thymus_morphology | 0.82078478 |
| 68 | MP0004859_abnormal_synaptic_plasticity | 0.81249520 |
| 69 | MP0002019_abnormal_tumor_incidence | 0.75887715 |
| 70 | MP0000613_abnormal_salivary_gland | 0.75587783 |
| 71 | MP0000569_abnormal_digit_pigmentation | 0.73695209 |
| 72 | MP0000477_abnormal_intestine_morphology | 0.71216075 |
| 73 | MP0008874_decreased_physiological_sensi | 0.70184747 |
| 74 | MP0006054_spinal_hemorrhage | 0.69862660 |
| 75 | MP0001191_abnormal_skin_condition | 0.68859652 |
| 76 | MP0005076_abnormal_cell_differentiation | 0.68496234 |
| 77 | MP0000609_abnormal_liver_physiology | 0.66488116 |
| 78 | MP0001881_abnormal_mammary_gland | 0.66245058 |
| 79 | MP0005388_respiratory_system_phenotype | 0.65515983 |
| 80 | MP0002133_abnormal_respiratory_system | 0.65515983 |
| 81 | MP0005464_abnormal_platelet_physiology | 0.65501691 |
| 82 | MP0002083_premature_death | 0.65385732 |
| 83 | MP0004885_abnormal_endolymph | 0.63341141 |
| 84 | MP0004130_abnormal_muscle_cell | 0.62096791 |
| 85 | MP0000003_abnormal_adipose_tissue | 0.61727713 |
| 86 | MP0003091_abnormal_cell_migration | 0.61079403 |
| 87 | MP0003656_abnormal_erythrocyte_physiolo | 0.60963738 |
| 88 | MP0008469_abnormal_protein_level | 0.59974827 |
| 89 | MP0000733_abnormal_muscle_development | 0.59235982 |
| 90 | MP0004270_analgesia | 0.59051052 |
| 91 | MP0009765_abnormal_xenobiotic_induced | 0.58417582 |
| 92 | MP0003045_fibrosis | 0.58242189 |
| 93 | MP0005174_abnormal_tail_pigmentation | 0.57101639 |
| 94 | MP0003879_abnormal_hair_cell | 0.55751273 |
| 95 | MP0005023_abnormal_wound_healing | 0.54358951 |
| 96 | MP0002909_abnormal_adrenal_gland | 0.53720160 |
| 97 | MP0000639_abnormal_adrenal_gland | 0.51852061 |
| 98 | MP0002822_catalepsy | 0.51695407 |
| 99 | MP0002138_abnormal_hepatobiliary_system | 0.51208620 |
| 100 | MP0008873_increased_physiological_sensi | 0.50899929 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B lymphocytopenia (HP:0010976) | 9.09660731 |
| 2 | Abnormality of B cell number (HP:0010975) | 9.09660731 |
| 3 | Agammaglobulinemia (HP:0004432) | 8.65883113 |
| 4 | Colitis (HP:0002583) | 8.15889224 |
| 5 | Recurrent sinusitis (HP:0011108) | 6.39819979 |
| 6 | Cellulitis (HP:0100658) | 6.24666311 |
| 7 | Papilloma (HP:0012740) | 6.16853912 |
| 8 | Verrucae (HP:0200043) | 6.16853912 |
| 9 | Inflammation of the large intestine (HP:0002037) | 5.92979606 |
| 10 | Recurrent bronchitis (HP:0002837) | 5.75212469 |
| 11 | Gastrointestinal inflammation (HP:0004386) | 5.62256861 |
| 12 | Chronic otitis media (HP:0000389) | 5.59323112 |
| 13 | Recurrent viral infections (HP:0004429) | 5.46081671 |
| 14 | Recurrent pneumonia (HP:0006532) | 4.54107271 |
| 15 | IgM deficiency (HP:0002850) | 4.47308318 |
| 16 | Meningitis (HP:0001287) | 4.46577187 |
| 17 | Gastrointestinal stroma tumor (HP:0100723) | 4.34456534 |
| 18 | Chronic sinusitis (HP:0011109) | 4.18473344 |
| 19 | Osteomyelitis (HP:0002754) | 3.77629266 |
| 20 | Recurrent lower respiratory tract infections (HP:0002783) | 3.46421627 |
| 21 | Nasal polyposis (HP:0100582) | 3.35840432 |
| 22 | Emphysema (HP:0002097) | 3.32125432 |
| 23 | Sepsis (HP:0100806) | 3.25308132 |
| 24 | Pustule (HP:0200039) | 3.19677132 |
| 25 | Bronchitis (HP:0012387) | 3.16677703 |
| 26 | Recurrent otitis media (HP:0000403) | 3.08067464 |
| 27 | Skin rash (HP:0000988) | 3.04569251 |
| 28 | Vacuolated lymphocytes (HP:0001922) | 3.00497261 |
| 29 | Abnormality of the nasal mucosa (HP:0000433) | 2.80501789 |
| 30 | Basal cell carcinoma (HP:0002671) | 2.78625728 |
| 31 | Increased IgE level (HP:0003212) | 2.72625291 |
| 32 | Cerebellar dysplasia (HP:0007033) | 2.69806961 |
| 33 | Interstitial pulmonary disease (HP:0006530) | 2.52637638 |
| 34 | Seborrheic dermatitis (HP:0001051) | 2.46164417 |
| 35 | Subacute progressive viral hepatitis (HP:0006572) | 2.45346696 |
| 36 | Bronchiectasis (HP:0002110) | 2.45203666 |
| 37 | Myositis (HP:0100614) | 2.42241833 |
| 38 | Restrictive lung disease (HP:0002091) | 2.42185524 |
| 39 | Onycholysis (HP:0001806) | 2.35848055 |
| 40 | Viral hepatitis (HP:0006562) | 2.30771182 |
| 41 | Vasculitis (HP:0002633) | 2.30042115 |
| 42 | Conjugated hyperbilirubinemia (HP:0002908) | 2.30010048 |
| 43 | Recurrent abscess formation (HP:0002722) | 2.27762028 |
| 44 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.26240409 |
| 45 | Abnormality of T cell physiology (HP:0011840) | 2.26240404 |
| 46 | Retinal atrophy (HP:0001105) | 2.22923198 |
| 47 | Recurrent fungal infections (HP:0002841) | 2.16291920 |
| 48 | Type II lissencephaly (HP:0007260) | 2.16192618 |
| 49 | Premature skin wrinkling (HP:0100678) | 2.10647471 |
| 50 | IgA deficiency (HP:0002720) | 2.09399107 |
| 51 | Conical tooth (HP:0000698) | 2.08839495 |
| 52 | Skin ulcer (HP:0200042) | 2.07488426 |
| 53 | Ulnar deviation of the wrist (HP:0003049) | 2.06285106 |
| 54 | Eczematoid dermatitis (HP:0000976) | 2.04948124 |
| 55 | Abnormality of macrophages (HP:0004311) | 2.03924373 |
| 56 | Lymphopenia (HP:0001888) | 2.03900881 |
| 57 | Inability to walk (HP:0002540) | 2.02682703 |
| 58 | Thyroiditis (HP:0100646) | 1.98923842 |
| 59 | Hepatoblastoma (HP:0002884) | 1.98818010 |
| 60 | Cervical subluxation (HP:0003308) | 1.98547839 |
| 61 | Dehydration (HP:0001944) | 1.93394136 |
| 62 | IgG deficiency (HP:0004315) | 1.90715691 |
| 63 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.87079055 |
| 64 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.86579774 |
| 65 | Urticaria (HP:0001025) | 1.85027072 |
| 66 | Erythema (HP:0010783) | 1.84318133 |
| 67 | Recurrent bacterial skin infections (HP:0005406) | 1.84251937 |
| 68 | Tented upper lip vermilion (HP:0010804) | 1.83914846 |
| 69 | Congenital glaucoma (HP:0001087) | 1.81612324 |
| 70 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.78938896 |
| 71 | Optic neuritis (HP:0100653) | 1.76836965 |
| 72 | Retrobulbar optic neuritis (HP:0100654) | 1.76836965 |
| 73 | Panhypogammaglobulinemia (HP:0003139) | 1.74368138 |
| 74 | Neoplasm of the adrenal cortex (HP:0100641) | 1.73304631 |
| 75 | Neutropenia (HP:0001875) | 1.71982847 |
| 76 | Abnormal tarsal ossification (HP:0008369) | 1.71932742 |
| 77 | Myocardial infarction (HP:0001658) | 1.66009668 |
| 78 | Obstructive lung disease (HP:0006536) | 1.64947861 |
| 79 | Chronic obstructive pulmonary disease (HP:0006510) | 1.64947861 |
| 80 | Hepatitis (HP:0012115) | 1.64368251 |
| 81 | Epidermoid cyst (HP:0200040) | 1.62127433 |
| 82 | Mediastinal lymphadenopathy (HP:0100721) | 1.61353348 |
| 83 | Teleangiectasia of the skin (HP:0100585) | 1.61266586 |
| 84 | Buphthalmos (HP:0000557) | 1.58501206 |
| 85 | Recurrent skin infections (HP:0001581) | 1.56442558 |
| 86 | Hypergammaglobulinemia (HP:0010702) | 1.56412769 |
| 87 | Abnormality of T cells (HP:0002843) | 1.55886090 |
| 88 | Abnormal foot bone ossification (HP:0010675) | 1.55410117 |
| 89 | Mucopolysacchariduria (HP:0008155) | 1.54049057 |
| 90 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.54049057 |
| 91 | Squamous cell carcinoma (HP:0002860) | 1.53702927 |
| 92 | Orchitis (HP:0100796) | 1.51607450 |
| 93 | Retinal dysplasia (HP:0007973) | 1.49458776 |
| 94 | Dry hair (HP:0011359) | 1.48603696 |
| 95 | Arthralgia (HP:0002829) | 1.48034201 |
| 96 | Stomach cancer (HP:0012126) | 1.47953843 |
| 97 | Intellectual disability, moderate (HP:0002342) | 1.47470483 |
| 98 | Progressive inability to walk (HP:0002505) | 1.45100893 |
| 99 | Pulmonary embolism (HP:0002204) | 1.43339906 |
| 100 | Pulmonary infiltrates (HP:0002113) | 1.42671851 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 6.33180530 |
| 2 | TAOK3 | 4.87574261 |
| 3 | IRAK3 | 4.34072607 |
| 4 | TYK2 | 3.18362771 |
| 5 | PRPF4B | 3.13820757 |
| 6 | MAP4K1 | 3.08212240 |
| 7 | NME2 | 3.02723687 |
| 8 | GRK6 | 2.98093840 |
| 9 | RIPK4 | 2.66127000 |
| 10 | KIT | 2.44593094 |
| 11 | MAP3K14 | 2.18096963 |
| 12 | MAP3K10 | 2.07780306 |
| 13 | RIPK1 | 1.84313568 |
| 14 | IKBKE | 1.83804097 |
| 15 | TBK1 | 1.81568077 |
| 16 | JAK1 | 1.71469349 |
| 17 | FES | 1.60194355 |
| 18 | EIF2AK3 | 1.59854198 |
| 19 | HIPK2 | 1.59080926 |
| 20 | TNIK | 1.58245937 |
| 21 | SIK2 | 1.53573251 |
| 22 | SYK | 1.53197170 |
| 23 | CSNK1A1L | 1.45109407 |
| 24 | MAP3K9 | 1.39351539 |
| 25 | BLK | 1.37804959 |
| 26 | CSF1R | 1.31969133 |
| 27 | FRK | 1.19171589 |
| 28 | MAP3K13 | 1.18496709 |
| 29 | NEK9 | 1.17881570 |
| 30 | KSR2 | 1.16076159 |
| 31 | PIK3CG | 1.07882357 |
| 32 | IKBKB | 1.06677349 |
| 33 | TAOK2 | 1.05039731 |
| 34 | BTK | 1.01118928 |
| 35 | IRAK4 | 0.99739534 |
| 36 | HCK | 0.98720737 |
| 37 | CAMK1G | 0.91964842 |
| 38 | EPHB1 | 0.89686252 |
| 39 | CSNK1G3 | 0.87167599 |
| 40 | PRKCH | 0.86624682 |
| 41 | ITK | 0.84729403 |
| 42 | CDK9 | 0.84267756 |
| 43 | PIM1 | 0.80985038 |
| 44 | LYN | 0.80879432 |
| 45 | FGFR4 | 0.80252615 |
| 46 | MAPK7 | 0.79113882 |
| 47 | JAK3 | 0.77359558 |
| 48 | MATK | 0.75250147 |
| 49 | CSNK1G2 | 0.73265520 |
| 50 | FGFR3 | 0.71327774 |
| 51 | TEC | 0.68667448 |
| 52 | PNCK | 0.68394079 |
| 53 | ALK | 0.62060065 |
| 54 | CSNK1G1 | 0.61878589 |
| 55 | TNK2 | 0.61051079 |
| 56 | LCK | 0.57842183 |
| 57 | KSR1 | 0.53300386 |
| 58 | SGK3 | 0.52287591 |
| 59 | RAF1 | 0.51481128 |
| 60 | CSK | 0.51007289 |
| 61 | FLT3 | 0.48661491 |
| 62 | BMX | 0.47764582 |
| 63 | EEF2K | 0.47244701 |
| 64 | NLK | 0.46922617 |
| 65 | JAK2 | 0.46783581 |
| 66 | FYN | 0.45740960 |
| 67 | MAP3K7 | 0.44889865 |
| 68 | CDK19 | 0.44624974 |
| 69 | PDK1 | 0.44372244 |
| 70 | CHUK | 0.42972682 |
| 71 | IRAK2 | 0.42613885 |
| 72 | PRKCQ | 0.42124053 |
| 73 | LRRK2 | 0.41594921 |
| 74 | PKN1 | 0.40979546 |
| 75 | CAMK1 | 0.39282098 |
| 76 | ABL1 | 0.37973317 |
| 77 | MAPK4 | 0.37235643 |
| 78 | SGK2 | 0.32224174 |
| 79 | WNK1 | 0.32099957 |
| 80 | ARAF | 0.31346373 |
| 81 | PRKD1 | 0.30721699 |
| 82 | TGFBR2 | 0.29053904 |
| 83 | FGFR2 | 0.28689226 |
| 84 | MAP3K1 | 0.25107377 |
| 85 | EGFR | 0.24205680 |
| 86 | PRKD2 | 0.23489660 |
| 87 | YES1 | 0.22272782 |
| 88 | BCKDK | 0.22206132 |
| 89 | STK11 | 0.21493345 |
| 90 | MAPK12 | 0.20870507 |
| 91 | PRKCI | 0.20860526 |
| 92 | PKN2 | 0.20088967 |
| 93 | CDK5 | 0.19809473 |
| 94 | PDGFRB | 0.19477306 |
| 95 | SIK1 | 0.18774543 |
| 96 | TTN | 0.18480761 |
| 97 | DYRK1B | 0.18453446 |
| 98 | INSR | 0.18013838 |
| 99 | CSNK1A1 | 0.16898068 |
| 100 | STK10 | 0.15877849 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 7.60013823 |
| 2 | Protein export_Homo sapiens_hsa03060 | 5.60889461 |
| 3 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 4.15794584 |
| 4 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 4.03116293 |
| 5 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 3.34411641 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.25127805 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.74640643 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.20768462 |
| 9 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.71140594 |
| 10 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.54534600 |
| 11 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.50630353 |
| 12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.46419741 |
| 13 | Other glycan degradation_Homo sapiens_hsa00511 | 1.45202702 |
| 14 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.39182009 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.37446084 |
| 16 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.33424217 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.29073750 |
| 18 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.27127878 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.25743215 |
| 20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.24163045 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.20510064 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.12214962 |
| 23 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.09486861 |
| 24 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.08112375 |
| 25 | Measles_Homo sapiens_hsa05162 | 0.98684597 |
| 26 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.97441422 |
| 27 | Malaria_Homo sapiens_hsa05144 | 0.95554507 |
| 28 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.94416318 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.90533927 |
| 30 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.89176678 |
| 31 | Allograft rejection_Homo sapiens_hsa05330 | 0.89100296 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.87337424 |
| 33 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.85614833 |
| 34 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.84031929 |
| 35 | Long-term potentiation_Homo sapiens_hsa04720 | 0.81896377 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 0.80379558 |
| 37 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.79097285 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.76176508 |
| 39 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75616714 |
| 40 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.72679437 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 0.70251280 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.67126608 |
| 43 | Endometrial cancer_Homo sapiens_hsa05213 | 0.65525546 |
| 44 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65148399 |
| 45 | Cocaine addiction_Homo sapiens_hsa05030 | 0.64963489 |
| 46 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.63883796 |
| 47 | Insulin secretion_Homo sapiens_hsa04911 | 0.60693388 |
| 48 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.59821143 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.57443476 |
| 50 | Hepatitis C_Homo sapiens_hsa05160 | 0.56548261 |
| 51 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.54012352 |
| 52 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.52740739 |
| 53 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.52372326 |
| 54 | Viral myocarditis_Homo sapiens_hsa05416 | 0.50814070 |
| 55 | Influenza A_Homo sapiens_hsa05164 | 0.49430273 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.49153006 |
| 57 | Renin secretion_Homo sapiens_hsa04924 | 0.48138872 |
| 58 | Circadian entrainment_Homo sapiens_hsa04713 | 0.45813876 |
| 59 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44006857 |
| 60 | Apoptosis_Homo sapiens_hsa04210 | 0.42340795 |
| 61 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.40188299 |
| 62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.39925468 |
| 63 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.38090468 |
| 64 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.35178305 |
| 65 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34738471 |
| 66 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.33322239 |
| 67 | Insulin resistance_Homo sapiens_hsa04931 | 0.32775589 |
| 68 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.32735479 |
| 69 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32682182 |
| 70 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.32281882 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.31705773 |
| 72 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.31455221 |
| 73 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.29874548 |
| 74 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.29734262 |
| 75 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.28696659 |
| 76 | Pertussis_Homo sapiens_hsa05133 | 0.27371894 |
| 77 | Platelet activation_Homo sapiens_hsa04611 | 0.26948935 |
| 78 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.24765532 |
| 79 | ABC transporters_Homo sapiens_hsa02010 | 0.24747514 |
| 80 | Prostate cancer_Homo sapiens_hsa05215 | 0.22677149 |
| 81 | Legionellosis_Homo sapiens_hsa05134 | 0.22355794 |
| 82 | Prion diseases_Homo sapiens_hsa05020 | 0.21203429 |
| 83 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.20943790 |
| 84 | Long-term depression_Homo sapiens_hsa04730 | 0.20190601 |
| 85 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.20165885 |
| 86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.20146746 |
| 87 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.19878979 |
| 88 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.17432568 |
| 89 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.16798016 |
| 90 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.15960818 |
| 91 | Glioma_Homo sapiens_hsa05214 | 0.15431314 |
| 92 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.14607843 |
| 93 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.14464971 |
| 94 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.13605956 |
| 95 | Colorectal cancer_Homo sapiens_hsa05210 | 0.12969717 |
| 96 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.12024312 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.11770043 |
| 98 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.11587890 |
| 99 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.11561514 |
| 100 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.11461611 |

